About OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA
OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA is a rare disease catalogued by Orphanet (ORPHA:254793). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA trials.
Search ClinicalTrials.gov for "OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA" or Orphanet code ORPHA:254793 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for OBSOLETE: Mitochondrial oxidative phosphorylation disorder due to a duplication of mitochondrial DNA. Updated daily.